Additionally, serum Endostatin levels have shown significant correlations with hemodynamics, NT-proBNP, and 6MWD, further supporting its potential as a biomarker for disease progression and poor prognosis in PAH. Here, COL18A1 is linked to pulmonary arterial hypertension.